AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21138709 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g/kg alcohol dose
Number of subjects: 187
Study 18324570 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Affect (NA)
Number of subjects: 157
Study 18324570 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic Features (SF)
Number of subjects: 157
Study 18324570 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Positive Affect/Anhedonia (PA)
Number of subjects: 157
Study 18324570 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Disturbance (IP)
Number of subjects: 157
Study 16979410 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (n = 15) instructed to walk at least 10000 steps per day 5 or more days per week for 6 weeks
Number of subjects: 30
Study 16979410 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (n = 15)
Number of subjects: 30
Study 16979410 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study 14656780 — intervention group
Group type: EXPERIMENTAL
Intervention: iv ondansetron 4 mg
Number of subjects: 70
Study 11477055 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflets (simple summary leaflet or FPA leaflet)
Number of subjects: 636
Study 11477055 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice
Number of subjects: 636
Study 11477055 — intervention group
Group type: COMPARATOR
Intervention: Neither (control group)
Number of subjects: 636
Study 11477055 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflets with past emergency contraception use
Number of subjects: 636
Study 11477055 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflets without past emergency contraception use
Number of subjects: 636
Study 10195004 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol (600 mgI kg‐1 bw, 320 mgI ml‐1)
Number of subjects: 100
Study 10195004 — intervention group
Group type: COMPARATOR
Intervention: Iopromide (600 mgI kg‐1 bw, 300 mgI ml‐1)
Number of subjects: 100
Study 7846101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary gamma-linolenic acid (GLA) at a dose of 3 g/day for humans and 3 mg/kg/day for rats for 4 months
Number of subjects: 24
Study 7846101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary gamma-linolenic acid (GLA) at a dose of 3 mg/kg/day for rats for 4 months
Number of subjects: 24
Study 3398015 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching skills program for residents; instruction and feedback during first and second postgraduate years
Number of subjects: 22
Study 3398015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 22
Study 30642365 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive motivational tool based on individual risks of pulmonary damage and prevention opportunities, reinforced by individualized text messages over a period of 3 months.
Number of subjects: 204
Study 30642365 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic obstructive pulmonary disease (COPD) diagnosis and severity assessment.
Number of subjects: 204
Study 28258815 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylazine (200 μg kg−1)
Number of subjects: 6
Study 28258815 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.875 μg kg−1)
Number of subjects: 6
Study 25635959 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal appliance therapy (OA)
Number of subjects: 64
Study 25635959 — intervention group
Group type: COMPARATOR
Intervention: Therapist-guided relaxation training (RT)
Number of subjects: 64
Study 23571234 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrus HD-OCT
Number of subjects: 19
Study 23571234 — intervention group
Group type: COMPARATOR
Intervention: Stratus OCT
Number of subjects: 19
Study 23571234 — intervention group
Group type: EXPERIMENTAL
Intervention: Bland-Altman analysis
Number of subjects: 19
Study 23571234 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean difference in central foveal zone
Number of subjects: 19
Study 21914508 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR version of EQ-5D
Number of subjects: 113
Study 21914508 — intervention group
Group type: COMPARATOR
Intervention: Paper version of EQ-5D
Number of subjects: 113
Study 21914508 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR version of EQ VAS
Number of subjects: 113
Study 21914508 — intervention group
Group type: COMPARATOR
Intervention: Paper version of EQ VAS
Number of subjects: 113
Study 19506455 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy with concurrent low-dose daily platinum chemotherapy
Number of subjects: 289
Study 19506455 — intervention group
Group type: COMPARATOR
Intervention: Standard fraction (conventionally fractionated) radiation therapy
Number of subjects: 289
Study 19506455 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy without concurrent chemotherapy
Number of subjects: 289
Study 19506455 — intervention group
Group type: COMPARATOR
Intervention: Treatment (general)
Number of subjects: 289
Study 19506455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower stage grouping
Number of subjects: 289
Study 19506455 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy (CHT)
Number of subjects: 289
Study 17075912 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus 10 sessions of twice‐weekly prolonged exposure (PE)
Number of subjects: 65
Study 17075912 — intervention group
Group type: COMPARATOR
Intervention: Sertraline alone
Number of subjects: 65
Study 14715071 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear SVM algorithm
Number of subjects: 59
Study 14715071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear SVM algorithm
Number of subjects: 59
Study 14715071 — intervention group
Group type: COMPARATOR
Intervention: SVM algorithms (comparison with PCA)
Number of subjects: 59
Study 11709564 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (250 mg daily) for 2 years
Number of subjects: 380
Study 11709564 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen for 2 more years
Number of subjects: 380
Study 9146325 — intervention group
Group type: EXPERIMENTAL
Intervention: Sculptor ring
Number of subjects: 221
Study 9146325 — intervention group
Group type: COMPARATOR
Intervention: Carpentier‐Edwards ring control
Number of subjects: 221
Study 9146325 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpentier‐Edwards ring historical
Number of subjects: 221
Study 8181847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin, 250 mg twice daily
Number of subjects: 100
Study 8181847 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin, 200 mg twice daily
Number of subjects: 100
Study 31471001 — intervention group
Group type: EXPERIMENTAL
Intervention: Website with vaccine information and interactive social media components
Number of subjects: 289
Study 31471001 — intervention group
Group type: EXPERIMENTAL
Intervention: Website with vaccine information only
Number of subjects: 289
Study 31471001 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 289
Study 30310936 — intervention group
Group type: EXPERIMENTAL
Intervention: Wallis interspinous device
Number of subjects: 72
Study 30310936 — intervention group
Group type: COMPARATOR
Intervention: Primary discectomy
Number of subjects: 72
Study 27278272 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 3/4 Chemotherapy-Induced Neutropenia (CIN)
Number of subjects: 271
Study 27278272 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 4 Chemotherapy-Induced Neutropenia (CIN)
Number of subjects: 271
Study 27278272 — intervention group
Group type: EXPERIMENTAL
Intervention: Area Over the Curve (AOC) of Absolute Neutrophil Count (ANC)
Number of subjects: 271
Study 25015695 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TR)
Number of subjects: 103
Study 25015695 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access (TF)
Number of subjects: 103
Study 22495908 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-Element Gymnastics (FEG)
Number of subjects: 66
Study 22495908 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 66
Study 20456443 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-lipoic acid eye drops (1%)
Number of subjects: 70
Study 20456443 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 70
Study 18794494 — intervention group
Group type: EXPERIMENTAL
Intervention: CTLA4Ig infusion
Number of subjects: 16
Study 15699673 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial bone grafting for orbital reconstruction
Number of subjects: 0
Study 15699673 — intervention group
Group type: COMPARATOR
Intervention: Exogenous materials
Number of subjects: 0
Study 15699673 — intervention group
Group type: COMPARATOR
Intervention: Iliac bone as autogenous source
Number of subjects: 0
Study 12842377 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxia for 8 hours
Number of subjects: 8
Study 12842377 — intervention group
Group type: COMPARATOR
Intervention: Air (control) for 8 hours
Number of subjects: 8
Study 10330648 — intervention group
Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine 0.5%
Number of subjects: 59
Study 10330648 — intervention group
Group type: COMPARATOR
Intervention: prednisolone acetate 1%
Number of subjects: 59
Study 8954018 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMA (5 mg/day)
Number of subjects: 13
Study 8954018 — intervention group
Group type: EXPERIMENTAL
Intervention: NETA (10 mg/day)
Number of subjects: 13
Study 8954018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8954018 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMA + FLU (250 mg, twice a day)
Number of subjects: 13
Study 8954018 — intervention group
Group type: EXPERIMENTAL
Intervention: NETA + FLU (250 mg, twice a day)
Number of subjects: 13
Study 8954018 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMA and NETA in CAI patients
Number of subjects: 13
Study 1935866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 83
Study 1935866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus oral Valium
Number of subjects: 83
Study 1935866 — intervention group
Group type: COMPARATOR
Intervention: Control group (CBT only)
Number of subjects: 83
Study 6216858 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 49
Study 6216858 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 49
Study 31321805 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidative allogeneic hematopoietic stem cell transplantation (allo-HSCT) within three months after CAR-T therapy for MRD-CR patients.
Number of subjects: 58
Study 31321805 — intervention group
Group type: COMPARATOR
Intervention: CAR-T therapy without subsequent allo-HSCT.
Number of subjects: 58
Study 29065279 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait retraining group (n = 166) received 2 weeks of gait retraining with real-time visual feedback.
Number of subjects: 320
Study 29065279 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 154) received treadmill running exercise without visual feedback.
Number of subjects: 320
Study 27883172 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate and a high calorie supplement (2108‐2416 kJ/day)
Number of subjects: 53
Study 27883172 — intervention group
Group type: COMPARATOR
Intervention: Placebo testosterone and low calorie supplement (142‐191 kJ/day)
Number of subjects: 53
Study 24706003 — intervention group
Group type: EXPERIMENTAL
Intervention: COCP pretreatment for 12-16 days
Number of subjects: 10
Study 24706003 — intervention group
Group type: COMPARATOR
Intervention: Non-COCP (control group)
Number of subjects: 10
Study 23017325 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of aspirin (81 mg) and EPA+DHA (3.4 g/d)
Number of subjects: 0
Study 23017325 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (81 mg) alone
Number of subjects: 0
Study 23017325 — intervention group
Group type: COMPARATOR
Intervention: EPA+DHA (3.4 g/d) alone
Number of subjects: 0
Study 20401350 — intervention group
Group type: COMPARATOR
Intervention: GanedenBC(30) - 1 capsule/day for 28 days
Number of subjects: 10
Study 18029844 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib mesylate treatment
Number of subjects: 63
Study 16265345 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 33
Study 16265345 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 33
Study 16265345 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 33
Study 12181623 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg per os daily
Number of subjects: 25
Study 12181623 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 100 mg intramuscularly every 10 days
Number of subjects: 25
Study 12181623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 10439571 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care-based chronic pain management program
Number of subjects: 40000
Study 7776167 — intervention group
Group type: COMPARATOR
Intervention: Disposable polyester foam sponge on a stick with non-foaming dentifrice; used for 1 and 3 minutes respectively.
Number of subjects: 67
Study 7776167 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially-available toothbrush; used for 1 and 3 minutes respectively.
Number of subjects: 67
Study 7776167 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable polyester foam sponge on a stick with non-foaming dentifrice; used 3 times a day for 1 week.
Number of subjects: 67
Study 2333483 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompting and reinforcement for different activities
Number of subjects: 24
Study 2333483 — intervention group
Group type: EXPERIMENTAL
Intervention: Only prompted
Number of subjects: 24
Study 2333483 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 111124 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate
Number of subjects: 5
Study 111124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 30636771 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk (BF)
Number of subjects: 4
Study 30636771 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented formula (F0)
Number of subjects: 4
Study 30636771 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with 65 mg/L bOPN (F65)
Number of subjects: 4
Study 30636771 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplemented with 130 mg/L bOPN (F130)
Number of subjects: 4
Study 29945669 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 45
Study 29945669 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 45
Study 29945669 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 45
Study 26740639 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) - 30 daily sessions of 90 min at 244 kPa
Number of subjects: 103
Study 26740639 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment - 30 daily sessions of 90 min breathing air at 125 kPa
Number of subjects: 103
Study 25108448 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART initiation (CD4 counts above 350 cells/mm(3))
Number of subjects: 44
Study 25108448 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation (CD4 counts below 250 cells/mm(3))
Number of subjects: 44
Study 25108448 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison of early vs deferred treatment
Number of subjects: 44
Study 25108448 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical evaluation after study period
Number of subjects: 44
Study 21983204 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial for a relatively healthy food item
Number of subjects: 75
Study 21983204 — intervention group
Group type: COMPARATOR
Intervention: Commercial for a less healthy food item
Number of subjects: 75
Study 21983204 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental encouragement to choose the healthy item
Number of subjects: 75
Study 21983204 — intervention group
Group type: COMPARATOR
Intervention: Choosing whichever item they preferred (no parental encouragement)
Number of subjects: 75
Study 20400916 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (5 x 10(9) colony‐forming units 3 times per day for 3 days)
Number of subjects: 64
Study 20400916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 20400916 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 64
Study 19902033 — intervention group
Group type: EXPERIMENTAL
Intervention: N. sativa oil 2.5 ml twice daily, atorvastatin 10 mg once a day, metformin 500 mg twice a day for 6 weeks
Number of subjects: 60
Study 19902033 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg once a day, metformin 500 mg twice a day for 6 weeks
Number of subjects: 60
Study 15830199 — intervention group
Group type: EXPERIMENTAL
Intervention: A3 adenosine receptor expression in PEX eyes
Number of subjects: 0
Study 15830199 — intervention group
Group type: COMPARATOR
Intervention: Normal and glaucomatous control eyes
Number of subjects: 0
Study 12794428 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein C concentrate (200 IU/kg, 400 IU/kg, or 600 IU/kg)
Number of subjects: 40
Study 12794428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11053728 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfluoroscopic electromechanical mapping
Number of subjects: 40
Study 11053728 — intervention group
Group type: COMPARATOR
Intervention: Echocardiographic data
Number of subjects: 40
Study 8940984 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep breathing (Kussmaul's respiration)
Number of subjects: 350
Study 8940984 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory distress
Number of subjects: 350
Study 1599984 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline combined with a low dose of flupentixol
Number of subjects: 0
Study 1599984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3902326 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine concentration higher than 370 mgI/ml
Number of subjects: 0
Study 3902326 — intervention group
Group type: COMPARATOR
Intervention: Iodine concentration 370 mgI/ml or lower
Number of subjects: 0
Study 30813966 — intervention group
Group type: EXPERIMENTAL
Intervention: Neratinib 240 mg/day
Number of subjects: 2816
Study 30813966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2816
Study 28976895 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg acetylsalicylic acid (ASA) continued
Number of subjects: 130
Study 28976895 — intervention group
Group type: COMPARATOR
Intervention: 100 mg acetylsalicylic acid (ASA) stopped 72 hours before extraction
Number of subjects: 130
Study 28976895 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel continued
Number of subjects: 130
Study 28976895 — intervention group
Group type: COMPARATOR
Intervention: 75 mg clopidogrel stopped 72 hours before extraction
Number of subjects: 130
Study 27390285 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 18
Study 27390285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 25091614 — intervention group
Group type: COMPARATOR
Intervention: Apical stimulation (Group A)
Number of subjects: 19
Study 25091614 — intervention group
Group type: EXPERIMENTAL
Intervention: Septal stimulation (Group B)
Number of subjects: 19
Study 21735072 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 174
Study 21735072 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 174
Study 21735072 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 174
Study 21735072 — intervention group
Group type: COMPARATOR
Intervention: Risperidone vs Olanzapine
Number of subjects: 174
Study 21735072 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 174
Study 19535419 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breast-feeding (EBF) for 4-6 months
Number of subjects: 1032
Study 19535419 — intervention group
Group type: COMPARATOR
Intervention: Exclusive breast-feeding (EBF) for <4 months
Number of subjects: 1032
Study 19535419 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of EBF (both groups)
Number of subjects: 1032
Study 17768466 — intervention group
Group type: EXPERIMENTAL
Intervention: Under-sized trephine (0.25 mm disparity)
Number of subjects: 40
Study 17768466 — intervention group
Group type: COMPARATOR
Intervention: Over-sized trephine (0.50 mm disparity)
Number of subjects: 40
Study 15871196 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% hyperbaric bupivacaine solutions
Number of subjects: 60
Study 15871196 — intervention group
Group type: COMPARATOR
Intervention: 0.375% isobaric bupivacaine solutions
Number of subjects: 60
Study 15871196 — intervention group
Group type: COMPARATOR
Intervention: 0.375% hypobaric bupivacaine solutions
Number of subjects: 60
Study 12411141 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung protective group (n = 34) perfused with hypothermic protective solution to the pulmonary artery
Number of subjects: 64
Study 12411141 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung protective group (n = 34)
Number of subjects: 64
Study 12411141 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 64
Study 9558544 — intervention group
Group type: EXPERIMENTAL
Intervention: ART restorations using Fuji II glass ionomer cement (GIC)
Number of subjects: 53
Study 7656906 — intervention group
Group type: EXPERIMENTAL
Intervention: MPA plus epirubicin
Number of subjects: 149
Study 7656906 — intervention group
Group type: COMPARATOR
Intervention: Estramustine phosphate
Number of subjects: 149
Study 2197860 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 66
Study 2197860 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 66
Study 2197860 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine and Ritodrine
Number of subjects: 66